BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 12837581)

  • 1. Cell-specific RNA-binding proteins in human disease.
    Musunuru K
    Trends Cardiovasc Med; 2003 Jul; 13(5):188-95. PubMed ID: 12837581
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonistic regulation of mRNA expression and splicing by CELF and MBNL proteins.
    Wang ET; Ward AJ; Cherone JM; Giudice J; Wang TT; Treacy DJ; Lambert NJ; Freese P; Saxena T; Cooper TA; Burge CB
    Genome Res; 2015 Jun; 25(6):858-71. PubMed ID: 25883322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myotonic dystrophy: RNA-mediated muscle disease.
    Wheeler TM; Thornton CA
    Curr Opin Neurol; 2007 Oct; 20(5):572-6. PubMed ID: 17885447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mis-splicing of Tau exon 10 in myotonic dystrophy type 1 is reproduced by overexpression of CELF2 but not by MBNL1 silencing.
    Dhaenens CM; Tran H; Frandemiche ML; Carpentier C; Schraen-Maschke S; Sistiaga A; Goicoechea M; Eddarkaoui S; Van Brussels E; Obriot H; Labudeck A; Gevaert MH; Fernandez-Gomez F; Charlet-Berguerand N; Deramecourt V; Maurage CA; Buée L; Lopez de Munain A; Sablonnière B; Caillet-Boudin ML; Sergeant N
    Biochim Biophys Acta; 2011 Jul; 1812(7):732-42. PubMed ID: 21439371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The CELF family of RNA binding proteins is implicated in cell-specific and developmentally regulated alternative splicing.
    Ladd AN; Charlet N; Cooper TA
    Mol Cell Biol; 2001 Feb; 21(4):1285-96. PubMed ID: 11158314
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gain of RNA function in pathological cases: Focus on myotonic dystrophy.
    Klein AF; Gasnier E; Furling D
    Biochimie; 2011 Nov; 93(11):2006-12. PubMed ID: 21763392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy.
    Philips AV; Timchenko LT; Cooper TA
    Science; 1998 May; 280(5364):737-41. PubMed ID: 9563950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RNA-binding proteins in human genetic disease.
    Lukong KE; Chang KW; Khandjian EW; Richard S
    Trends Genet; 2008 Aug; 24(8):416-25. PubMed ID: 18597886
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A muscleblind knockout model for myotonic dystrophy.
    Kanadia RN; Johnstone KA; Mankodi A; Lungu C; Thornton CA; Esson D; Timmers AM; Hauswirth WW; Swanson MS
    Science; 2003 Dec; 302(5652):1978-80. PubMed ID: 14671308
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy.
    Ho TH; Bundman D; Armstrong DL; Cooper TA
    Hum Mol Genet; 2005 Jun; 14(11):1539-47. PubMed ID: 15843400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RNA binding proteins in the regulation of heart development.
    Blech-Hermoni Y; Ladd AN
    Int J Biochem Cell Biol; 2013 Nov; 45(11):2467-78. PubMed ID: 23973289
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ancient antagonism between CELF and RBFOX families tunes mRNA splicing outcomes.
    Gazzara MR; Mallory MJ; Roytenberg R; Lindberg JP; Jha A; Lynch KW; Barash Y
    Genome Res; 2017 Aug; 27(8):1360-1370. PubMed ID: 28512194
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myotonic syndromes.
    Mankodi A; Thornton CA
    Curr Opin Neurol; 2002 Oct; 15(5):545-52. PubMed ID: 12351998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sense and Antisense DMPK RNA Foci Accumulate in DM1 Tissues during Development.
    Michel L; Huguet-Lachon A; Gourdon G
    PLoS One; 2015; 10(9):e0137620. PubMed ID: 26339785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative splicing of myomesin 1 gene is aberrantly regulated in myotonic dystrophy type 1.
    Koebis M; Ohsawa N; Kino Y; Sasagawa N; Nishino I; Ishiura S
    Genes Cells; 2011 Sep; 16(9):961-72. PubMed ID: 21794030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-specific change in alternative splicing of Tau exon 6 in myotonic dystrophy type 1.
    Leroy O; Wang J; Maurage CA; Parent M; Cooper T; Buée L; Sergeant N; Andreadis A; Caillet-Boudin ML
    Biochim Biophys Acta; 2006 Apr; 1762(4):460-7. PubMed ID: 16487687
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Celf1 regulates cell cycle and is partially responsible for defective myoblast differentiation in myotonic dystrophy RNA toxicity.
    Peng X; Shen X; Chen X; Liang R; Azares AR; Liu Y
    Biochim Biophys Acta; 2015 Jul; 1852(7):1490-7. PubMed ID: 25887157
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Region-specific alternative splicing in the nervous system: implications for regulation by the RNA-binding protein NAPOR.
    Zhang W; Liu H; Han K; Grabowski PJ
    RNA; 2002 May; 8(5):671-85. PubMed ID: 12022233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aberrantly spliced alpha-dystrobrevin alters alpha-syntrophin binding in myotonic dystrophy type 1.
    Nakamori M; Kimura T; Kubota T; Matsumura T; Sumi H; Fujimura H; Takahashi MP; Sakoda S
    Neurology; 2008 Feb; 70(9):677-85. PubMed ID: 18299519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myotonic Dystrophy and Developmental Regulation of RNA Processing.
    Thomas JD; Oliveira R; Sznajder ŁJ; Swanson MS
    Compr Physiol; 2018 Mar; 8(2):509-553. PubMed ID: 29687899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.